10
Totality of Scientific Evidence in the Development of ABP 980, a Biosimilar to Trastuzumab.pdf
Totality of Scientific Evidence in the Development of ABP 980, a Biosimilar to Trastuzumab
10
the path towards a tailored clinical biosimilar development.[2020][biodrugs].pdf
the path towards a tailored clinical biosimilar development.[2020][biodrugs]
9
patients´ beliefs and behaviours are associated with perceptions of safety and concerns in a hypothetical biosimilar switch.[2020][rheumatol int].pdf
patients´ beliefs and behaviours are associated with perceptions of safety and concerns in a hypothetical biosimilar switch.[2020][rheumatol int]
2
P137 Phase I clinical trial comparing PK and safety of trastuzumab and its biosimilar candidate CT-P6.pdf
P137 Phase I clinical trial comparing PK and safety of trastuzumab and its biosimilar candidate CT-P6
2
Biosimilar Glargine Insulin Implications for Prescribers and Patients.pdf
Biosimilar Glargine Insulin Implications for Prescribers and Patients
16
an overview of patents on therapeutic monoclonal antibodies in europe_ are they a hurdle to biosimilar market entry_[2020][mabs].pdf
an overview of patents on therapeutic monoclonal antibodies in europe_ are they a hurdle to biosimilar market entry_[2020][mabs]
11
a rapid method for relative quantification of n-glycans from a therapeutic monoclonal antibody during trastuzumab biosimilar development.[2020][mab.pdf
a rapid method for relative quantification of n-glycans from a therapeutic monoclonal antibody during trastuzumab biosimilar development.[2020][mab
9
patients´ perspectives after switching from infliximab to biosimilar ct-p13 in patients with inflammatory bowel disease_ a 12-month prospective coh.pdf
patients´ perspectives after switching from infliximab to biosimilar ct-p13 in patients with inflammatory bowel disease_ a 12-month prospective coh

向豆丁求助:有没有biosimilar?

如要投诉违规内容,请联系我们按需举报;如要提出意见建议,请到社区论坛发帖反馈。